Nonetheless, a prospective longitudinal cohort study with a 3.09-year follow-up reported that serum RBP4 concentrations were positively correlated with incident NAFLD and negatively correlated with NAFLD regression (51). Here, RBP4 is linked to metabolic dysfunction-associated steatotic liver disease.